Homayoun Sameyih Najafabadi, a member of the Health and Treatment Commission of the Islamic Consultative Assembly, has reported “serious” drug shortages and a significant increase in drug prices in Iran, and said that the difficulty of transferring money and the increase in import costs have made the drug supply situation more complicated.